ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
68 103,09
0,56%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Pharmaceutical Companies (PRX)

  7. Pharmaceutical Companies (PRX) Actualités

PRX

Pharmacutical (PRX)

Pharmaceutical Companies
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:PRX
DateHeureSourceTitreSymboleSociété
10/08/201515h10Dow Jones NewsEndo International Beats Revenue, Earnings TargetsNYSE:PRXPharmaceutical Companies
26/05/201516h19PR Newswire (US)Par Specialty Pharmaceuticals Launches Cortisporin®-TC Otic SuspensionNYSE:PRXPharmaceutical Companies
18/05/201522h09Dow Jones NewsStocks Gain; Dow, S&P 500 Flirt With RecordsNYSE:PRXPharmaceutical Companies
18/05/201518h18Dow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 4th UpdateNYSE:PRXPharmaceutical Companies
18/05/201517h53Dow Jones NewsU.S. Stocks Waver After Dow Touches RecordNYSE:PRXPharmaceutical Companies
18/05/201517h05Dow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 3rd UpdateNYSE:PRXPharmaceutical Companies
18/05/201516h37Dow Jones NewsU.S. Stocks Edge Higher; Dow Hits RecordNYSE:PRXPharmaceutical Companies
18/05/201515h20Dow Jones NewsEndo to Buy Par PharmaNYSE:PRXPharmaceutical Companies
18/05/201514h53Dow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 2nd UpdateNYSE:PRXPharmaceutical Companies
18/05/201514h50Dow Jones NewsU.S. Stock Futures Edge LowerNYSE:PRXPharmaceutical Companies
18/05/201513h44Dow Jones NewsEndo to Buy Generics Maker Par Pharma for About $8 Billion -- UpdateNYSE:PRXPharmaceutical Companies
18/03/201421h32Edgar (US Regulatory)Annual Report (10-k)NYSE:PRXPharmaceutical Companies
20/02/201420h45Edgar (US Regulatory)Current Report Filing (8-k)NYSE:PRXPharmaceutical Companies
19/02/201421h08Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)NYSE:PRXPharmaceutical Companies
12/11/201314h06Edgar (US Regulatory)Quarterly Report (10-q)NYSE:PRXPharmaceutical Companies
28/08/201312h01Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:PRXPharmaceutical Companies
27/08/201317h36Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)NYSE:PRXPharmaceutical Companies
27/08/201317h36Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:PRXPharmaceutical Companies
15/08/201314h13Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NYSE:PRXPharmaceutical Companies
11/02/201317h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:PRXPharmaceutical Companies
16/10/201214h58Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)NYSE:PRXPharmaceutical Companies
10/10/201216h59Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NYSE:PRXPharmaceutical Companies
09/10/201217h03Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:PRXPharmaceutical Companies
05/10/201221h56Edgar (US Regulatory)(25-NSE)NYSE:PRXPharmaceutical Companies
01/10/201217h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NYSE:PRXPharmaceutical Companies
28/09/201217h40PR Newswire (US)Par Announces Completion Of Acquisition By TPGNYSE:PRXPharmaceutical Companies
27/09/201222h17Edgar (US Regulatory)Current report filing (8-K)NYSE:PRXPharmaceutical Companies
25/09/201216h06Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NYSE:PRXPharmaceutical Companies
25/09/201201h06Dow Jones NewsADT, Pentair to Gain Spots on S&P 500, Replacing Lexmark, DeVryNYSE:PRXPharmaceutical Companies
25/09/201200h01PR Newswire (US)ADT, Pentair Set to Join the S&P 500; Lexmark, DeVry to Join the S&P MidCap 400 and MarketAxess to Join the S&P SmallCap 600NYSE:PRXPharmaceutical Companies
 Showing the most relevant articles for your search:NYSE:PRX

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
NYSE
MCD
McDonalds
EU
BEL20
Bel 20
EU
PX1
CAC 40
EU
DG
Vinci
EU
LR
Legrand
NYSE
KO
Coca Cola
USI
USTECH100
US Tech 100
EU
VIV
Vivendi
NASDAQ
MSFT
Microsoft
NYSE
NKE
Nike
EU
BNP
BNP Paribas
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés